Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-08
Jawahar Lal Mehta profile photo

Jawahar Lal Mehta

Federal Grant PI High Impact

Distingusihed Professor

Also affiliated: United States Department of Veterans Affairs (1990–1998); UF Health Shands Hospital (2015); University of Arizona (2021); University of Georgia (1987); University of Arkansas Medical Center (2020–2026); Veterans Health Administration (1990–2021); University of Florida Health (1981–2015); University of Florida (1981–2015); Central Arkansas Veterans Healthcare System (2003–2025); North Florida/South Georgia Veterans Health System (1994–1998); John L. McClellan Memorial Veterans Hospital (2024)

Internal Med, College of Medicine

33 h-index 122 pubs 6,515 cited

  • Humans
  • Animals
  • Male
  • Scavenger Receptors, Class E
  • Female
  • Middle Aged
  • Aged
  • Adult
  • Endothelium, Vascular
  • Cells, Cultured
  • Mice
  • Lipoproteins, LDL
  • Rats
  • Atherosclerosis
  • Coronary Disease

Biography and Research Information

OverviewAI-generated summary

Jawahar Lal Mehta, Distinguished Professor in Internal Medicine at the University of Arkansas for Medical Sciences College of Medicine, investigates cardiovascular disease mechanisms, focusing on the role of LOX-1 in atherogenesis. His research has been supported by federal grants, including an NIH award where he served as PI for work on PCSK9 as a novel target for myocardial ischemia treatment. Mehta has published extensively on topics related to cardiovascular health, oxidative stress, and metabolic syndrome, with his work appearing in numerous peer-reviewed journals. His scholarship metrics include an h-index of 33, with over 6,600 citations across 117 publications, indicating a significant research impact. He leads a research group and collaborates with several colleagues at the University of Arkansas for Medical Sciences, including Nishank Jain and Subhi J. Al’Aref, with whom he has co-authored multiple publications.

Mehta is recognized as a high-impact researcher, evidenced by his highly cited status. His recent publications include contributions to guidelines for monitoring autophagy, reflecting a broader engagement with fundamental biological processes. He has also published on trends in infective endocarditis and the role of specific cellular receptors in disease contexts. His work on deletion of LOX-1 in LDLR knockout mice demonstrates a focus on animal models to elucidate disease pathways.

Metrics

  • h-index: 33
  • Publications: 122
  • Citations: 6,515

Positions

  • Distingusihed Professor 2000–present
    University of Arkansas System ORCID
  • VA Senior Clinician-scientist 1977–present
    Veterans Health Administration Medicine ORCID
  • Distingusihed Professor publications 2002–2026
    University of Arkansas for Medical Sciences Internal Med, College of Medicine Institutional directory
  • Associate Editor 2021–2025
    OAE Publishing Inc. Editorial Board ORCID

Selected Publications

  • Mid‐ and Long‐Term Risk of Venous Thromboembolism Among Female Breast Cancer Survivors: A Nationwide Cohort Study (2026)
    International Journal of Cancer DOI OpenAlex
  • Evaluation of Incomplete Stent Apposition of Flow Diverters at the Aneurysm Neck on Aneurysm Healing and Endothelialization: An OCT- and Histopathology-Based Study (2026)
    American Journal of Neuroradiology DOI OpenAlex
  • Time-Dependent Association Between Breast Cancer and Risk of Ischemic Stroke (2026)
  • D101-04 Lox-1 Promotes Lung Homeostasis and Repair via Neutrophils in a Pathogen-Dependent Manner (2026)
  • Disulfidptosis: A novel cell death mechanism with pathological significance and therapeutic potential in diseases (2026)
  • Knowledge gaps in revascularization strategies in the setting of type II myocardial infarction: A common clinical dilemma in contemporary practices (2026)
  • Functional Biochemistry of Iron and Its Cardiopulmonary Impact (2026)
  • Remodelling-derived pre-β1 and remnant HDL particles: a snapshot of reverse cholesterol transport dynamics and efficiency (2025)
  • LOX-1+ Neutrophils Exhibit a Distinct Phenotype Associated With Prevention of Lung Injury During Pneumonia (2025)
  • Molecular Insights into Ischemia–Reperfusion Injury in Coronary Artery Disease: Mechanisms and Therapeutic Implications: A Comprehensive Review (2025)
    11 citations DOI OpenAlex
  • Addressing myocardial infarction in South-Asian populations: risk factors and machine learning approaches (2025)
    3 citations DOI OpenAlex
  • The pleiotropic effects of PCSK9 in cardiovascular diseases beyond cholesterol metabolism (2025)
    3 citations DOI OpenAlex
  • Reply (2024)
    1 citation DOI OpenAlex
  • Applications of ChatGPT in Heart Failure Prevention, Diagnosis, Management, and Research: A Narrative Review (2024)
    8 citations DOI OpenAlex
  • Positive Implications of Introducing Mindfulness Techniques as a Platform for Preoperative Stress Reduction to Improve Patient Outcomes Postpercutaneous Coronary Intervention (2024)

View all publications on OpenAlex →

Federal Grants 1

VA Contact PI Oct 2009 - Aug 2022

PCSK9-A novel target for the treatment of myocardial ischemia

Administered by Central Arkansas Veterans Healthcare System I01

Grants & Funding

As listed on this researcher's institutional profile. Federal awards with verified records are shown above.

  • Anti-myeloma efficacy of FAP inhibitor in ex vivo and in vivo systems for primary myeloma Vantia Therapeutics Ltd. Principal Investigator
  • Structure based drug design for atherosclerosis targeted at LOX-1, a receptor for oxidized low-density lipoprotein American Heart Association (SouthWest Affiliate) Co-Investigator
  • Regulation of LOX-1 Expression by Pioglitazone Takeda Principal Investigator
  • TOPCAT: Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone AnTagonist NIH/Nat. Heart, Lung & Blood Institute via New England Research Insts., Inc. Principal Investigator

Collaboration Network

575 Collaborators 171 Institutions 14 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics